The etiology of pancreatic manifestations in patients with inflammatory bowel disease

T Iida, K Wagatsuma, D Hirayama, Y Yokoyama… - Journal of clinical …, 2019 - mdpi.com
Inflammatory bowel disease (IBD) is an idiopathic chronic and recurrent condition that
comprises Crohn's disease and ulcerative colitis. A pancreatic lesion is one of the …

The effects of probiotics, prebiotics and synbiotics on the reduction of IBD complications, a periodic review during 2009–2020

A Darb Emamie, M Rajabpour… - Journal of Applied …, 2021 - academic.oup.com
Aims To perform a systematic review on randomized controlled trials to examine the efficacy
of probiotics, prebiotics and synbiotics in the treatment of IBD. Methods and Results …

5‐aminosalicylate maintenance is not superior to no maintenance in patients with newly diagnosed Crohn's disease—A nationwide cohort study

O Atia, I Goren, TS Fischler… - Alimentary …, 2023 - Wiley Online Library
Summary Background 5‐aminosalicylates (5‐ASA) are widely used in Crohn's disease (CD)
despite guidelines advising otherwise. We aimed to assess in nationwide study the …

Protective effect of San Huang Pill and its bioactive compounds against ulcerative colitis in Drosophila via modulation of JAK/STAT, apoptosis, Toll, and Nrf2/Keap1 …

B Li, M Xiu, L He, S Zhou, S Yi, X Wang, W Cao… - Journal of …, 2024 - Elsevier
Abstract Ethnopharmacological relevance San Huang Pill (SHP) is a prescription in
Dunhuang Ancient Medical Prescription, which has the efficacy of heat-clearing and …

Drug-induced acute pancreatitis: prevalence, causative agents, and outcomes

P Chadalavada, CR Simons-Linares, P Chahal - Pancreatology, 2020 - Elsevier
Background We sought to study the causative drugs, prevalence and outcomes of drug-
induced acute pancreatitis (DIAP). Methods Retrospective study of DIAP patients at a tertiary …

Pancreatic disorders in patients with inflammatory bowel disease

ML Montenegro, JE Corral, FJ Lukens, B Ji… - Digestive diseases and …, 2022 - Springer
Inflammatory bowel disease (IBD) can involve multiple organ systems, and pancreatic
manifestations of IBD are not uncommon. The incidence of several pancreatic diseases is …

Drug-induced acute pancreatitis due to medications used for inflammatory bowel disease: A VigiBase pharmacovigilance database study

AA Lee, S Gupta, M Labban, FT Cao, QD Trinh… - Pancreatology, 2023 - Elsevier
Background Nearly all medications used for inflammatory bowel disease (IBD) have been
reported as causes of acute pancreatitis (AP), with the thiopurines being among the most …

Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review

J Pan, Z Li, C Ye, X Zhang, Q Yang… - … and Clinical Risk …, 2025 - Taylor & Francis
Objective Mesalazine is a widely used medication for treating mild to moderate inflammatory
bowel disease (IBD). First identified as a potential cause of acute pancreatitis (AP) in 1989 …

[HTML][HTML] Inflammatory bowel disease does not alter the clinical features and the management of acute pancreatitis: A prospective, multicentre, exact-matched cohort …

D Dohos, N Farkas, A Váradi, B Erőss, A Párniczky… - Pancreatology, 2022 - Elsevier
Objective and aims Acute pancreatitis in inflammatory bowel disease occurs mainly as an
extraintestinal manifestation or a side effect of medications. We aimed to investigate the …

Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis

PJ Hegyi, Z Szakács, N Faluhelyi, BC Németh, J Bajor… - Pancreatology, 2020 - Elsevier
Drug-induced acute pancreatitis (DIAP) is an often-neglected entity where the disorder is the
consequence of the toxic effects of various agents applied to treat potentially life-threatening …